By Anoushka Banerjee, Policy Intern at Protect Our Breasts (Biochemistry and Legal Studies)
When I was just 16 years old, I joined Planned Parenthood as a student educator. I was struck by how many people came through our doors not only for reproductive care but also for lifesaving cancer screenings. Many of them were young, uninsured, or juggling multiple jobs. Some whispered that it had been years since their last doctor’s visit; others had never had one. What united them all was the quiet relief of finding a clinic that treated them with dignity, and on a sliding scale they could actually afford.
What is Prevention?
When we talk about cancer prevention, we’re really talking about two complementary strategies, both critical to saving lives:
Primary prevention means stopping cancer before it starts—reducing exposure to environmental carcinogens in everyday products, advocating for safer chemicals in manufacturing, and addressing systemic risk factors that increase cancer rates in vulnerable communities.
Secondary prevention means catching cancer early through accessible screening programs like mammograms and Pap tests, when treatment is most effective and survival rates are highest.
At Protect Our Breasts, we champion both approaches: protecting people from harmful exposures while ensuring everyone has access to lifesaving early detection. This piece focuses primarily on secondary prevention through accessible screening programs, but both strategies are essential to reducing cancer’s devastating toll on our communities.
Seeing the Bigger Picture
Now, as a Policy Intern at Protect Our Breasts, I’ve started to see how much bigger the picture really is. What happens in the halls of power doesn’t stay there, it ripples into the clinics, waiting rooms, and lives of people who depend on affordable care.
Across the country, community health centers, federally qualified health clinics (FQHCs), rural health clinics, mobile mammography programs, and faith-based health organizations form a vital safety net for cancer screening services. These providers serve as the first and often only point of access for millions of Americans seeking breast and cervical cancer screenings. Over the past year, we’ve seen how funding disruptions can upend the programs that communities rely on. When federal grants are delayed or frozen, the impact is immediate: clinics scramble to cover costs, some scale back services, and patients face fewer options, longer waits, or higher out-of-pocket expenses.
These kinds of funding disruptions send a dangerous message: that preventive care is optional.
For clinics operating on tight budgets, whether they’re in rural communities, urban neighborhoods, or mobile units traveling to underserved areas, these interruptions can mean cutting outreach programs, reducing staff, or limiting sliding-scale payment options. And when one clinic loses its footing, entire regions can lose their only accessible source of care.
The Lifeline of Sliding Scale Programs
The Planned Parenthood clinic where I worked was just one of thousands of community health centers nationwide that rely on sliding scale payment models, a cornerstone of equitable healthcare. This approach allows patients to pay what they can based on income, ensuring that financial barriers don’t prevent early detection of breast and cervical cancer. From FQHCs in urban centers to rural health clinics serving farming communities, this model makes the difference between care and neglect. This is critical because cancer doesn’t discriminate, but access to early screening and treatment often does.
As I spoke with patients during my time as a student educator, I heard stories of mothers scheduling mammograms between shifts, college students coming in for their first Pap test, and uninsured women who had been turned away elsewhere. For many, the affordability of these screenings was the deciding factor between care and neglect. The sliding scale made that difference possible, but it also depends heavily on government funding streams like Title X, the National Breast and Cervical Cancer Early Detection Program, and Medicaid reimbursements. When those are disrupted, the ripple effects are immediate and deeply felt.
Why Sustained, Bipartisan Support Matters
Administrative changes can ripple through these programs in devastating ways. When leadership shifts, so do funding priorities and regulatory guidelines. Even temporary freezes or delays in grants can jeopardize entire networks of preventive health providers. Each policy change, no matter how technical it seems, can mean fewer screenings, reduced staff, or higher out-of-pocket costs for patients who already face systemic barriers to care.
That’s precisely why regardless of which party holds power, prevention funding must remain protected. Every administration has a responsibility to ensure cancer screening access remains stable and accessible. The economics make it clear: investing in early detection saves lives and dramatically reduces healthcare costs down the line. Treating late-stage cancers is exponentially more expensive than catching them early, making prevention programs not just a moral imperative but a fiscal one.
During my time in advocacy and education, I’ve learned that the most vulnerable populations, women of color, rural communities, and low-income individuals, bear the brunt when funding becomes unstable. When clinics lose resources, they don’t just lose doctors or nurses. They lose trust, outreach programs, and the ability to catch cancers early, when treatment is most effective and survival rates are highest.
Policy changes, no matter how technical they seem, translate directly into patient outcomes. A delayed grant can mean a postponed screening. A funding cut can mean a mobile mammography unit that no longer reaches rural areas. For patients who already face systemic barriers to care, transportation challenges, inflexible work schedules, lack of insurance, each additional obstacle can become insurmountable. These are not abstract budget line items; they are mothers, daughters, sisters, brothers, fathers, and friends whose lives hang in the balance. Breast cancer affects everyone, regardless of gender, and our healthcare system must reflect that reality.
Bridging the Policy and the Personal
Working in policy now, I can see how these decisions, often made in distant government buildings, directly impact the faces I once saw in clinic waiting rooms. The data may show trends, but I’ve witnessed the human side: fear, hope, and gratitude woven into each screening visit.
That’s why part of our mission at Protect Our Breasts, educating about environmental exposures and empowering young people to make safer consumer choices, must be paired with strong advocacy for accessible preventive healthcare. Environmental toxicants and carcinogens don’t exist in a vacuum; they interact with systems of inequity. Without programs like our community clinics providing low-cost cancer screenings, those most affected by environmental risk factors may never get the chance to detect illness early enough to act.
Protecting Prevention Through Policy
As a new generation of health advocates, it’s on us to understand that policy is prevention. Here’s what sustained commitment looks like:
Protecting Title X funding ensures family planning clinics can continue offering cancer screenings alongside reproductive care.
Expanding the National Breast and Cervical Cancer Early Detection Program reaches more low-income and uninsured women in every state.
Strengthening support for FQHCs and rural health clinics prevents care deserts from expanding in underserved communities.
Ensuring Medicaid coverage remains strong so that sliding scale models remain viable for clinics serving our most vulnerable populations.
These aren’t partisan issues—they’re public health essentials. Prevention saves lives, but only when people can access it. Cancer doesn’t wait for political cycles to end. A delayed screening can mean the difference between stage one and stage three, between a treatable diagnosis and a terminal one. We need policies that invest in the full ecosystem of community clinics, preserve the autonomy of providers across all sectors, and keep sliding scale models sustainable.
Every patient who walks through the doors of a community health center deserves not just compassionate care, but the assurance that shifting politics won’t strip that care away.
A Call to Sustain the Promise of Care
Looking back on my journey, from student educator to policy intern, I’ve learned that advocacy begins with listening. Listening to patients who need care, to educators who deliver it, and to policymakers who decide its fate. But listening is only the first step, action is what creates change.
At Protect Our Breasts, our work continues that legacy of listening and acting: protecting our bodies not just from toxic chemicals, but from the toxic effects of neglecting equitable healthcare policy. We cannot afford to let political tides wash away decades of progress in cancer prevention.
Here’s how you can join us:
Educate yourself and others. Learn about the carcinogens in everyday products and the importance of accessible screening. Knowledge is the first line of defense. Follow Protect Our Breasts on social media and share our resources with your communities.
Make your voice heard. Contact your representatives and demand sustained funding for Title X, the National Breast and Cervical Cancer Early Detection Program, and community health centers. Tell them prevention is not negotiable, it’s a necessity.
Find and use local screening resources: Visit FindAHealthCenter.HRSA.gov to locate federally qualified health centers near you that offer affordable cancer screenings
Support community health infrastructure. Whether through volunteering, donations, or simply spreading awareness, strengthen the clinics that serve as healthcare lifelines in your community.
Choose safer products. Use your purchasing power to support companies that prioritize safety over harmful chemicals. Every choice sends a market signal that consumer health matters.
Advocate for policy change. Join Protect Our Breasts in pushing for stronger regulations on environmental carcinogens and robust support for preventive healthcare access.
For every person who has depended on a sliding scale screening, for every life saved by early detection, we must continue to fight for a healthcare system that puts people, and prevention, first, regardless of where they seek care or which administration is in power.
The faces I saw in that clinic waiting room years ago are still out there, still needing care, still deserving dignity. This work is for them, and for everyone who comes after. Together, we can ensure that prevention remains a promise we keep.